Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents

被引：29

作者：

Francis, Stuart ^{[1
]}

Croft, Daniel ^{[1
]}

Schtittelkopf, Alexander W. ^{[1
]}

Parry, Charles ^{[1
]}

Pughese, Angelo ^{[1
]}

Cameron, Ken ^{[1
]}

Claydon, Sophie ^{[1
]}

Drysdale, Martin ^{[1
,4
]}

Gardner, Claire ^{[1
]}

Gohlke, Andrea ^{[1
]}

Goodwin, Gillian ^{[1
]}

Gray, Christopher H. ^{[1
]}

Konczal, Jennifer ^{[1
]}

McDonald, Laura ^{[1
]}

Mezna, Mokdad ^{[1
]}

Pannifer, Andrew ^{[1
,5
]}

Paul, Nikki R. ^{[2
]}

Machesky, Laura ^{[2
,3
]}

McKinnon, Heather ^{[1
]}

Bower, Justin ^{[1
]}

机构：

[1] CRUK Beatson Inst, Drug Discovery Unit, Glasgow G61 1BD, Lanark, Scotland

[2] CRUK Beatson Inst, Cell Migrat Lab, Glasgow G61 1BD, Lanark, Scotland

[3] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland

[4] Broad Inst, Cambridge, MA 02142 USA

[5] Med Discovery Catapult, Alderly Pk, Alderley Edge SK10 4TG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 08期

关键词：

Virtual screening; Fragments; Drug discovery; Medicinal chemistry; Cancer; LIGAND; CANCER;

D O I：

10.1016/j.bmcl.2019.01.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies.

引用

页码：1023 / 1029

页数：7

共 50 条

[21] Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors
Zhu, Qihua
Wang, Xuyan
Chu, Zhaoxing
He, Guangwei
Dong, Guangping
Xu, Yungen
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 1993 - 1996
[22] Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
Wang, Jie
Zhou, Chi
Li, Bo
Liu, Huaqing
Zhang, Hui
Liu, Lei
MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (04) : 687 - 702
[23] Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N′-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities
Iraji, Aida
Khoshneviszadeh, Mahsima
Bakhshizadeh, Pegah
Edraki, Najmeh
Khoshneviszadeh, Mehdi
MEDICINAL CHEMISTRY, 2020, 16 (07) : 892 - 902
[24] Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities
Xi, Jian-Bei
Fang, Yan-Fen
Frett, Brendan
Zhu, Meng-Li
Zhu, Tong
Kong, Yan-Nan
Guan, Feng-Jie
Zhao, Yun
Zhang, Xiong-Wen
Li, Hong-Yu
Ma, Ming-Liang
Hu, Wenhao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 : 1083 - 1106
[25] Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors
Li, Jun
Li, Jie
Zhang, Jiaojiao
Shi, Jiantao
Ding, Shi
Liu, Yajing
Chen, Ye
Liu, Ju
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (05) : 559 - 570
[26] Design, synthesis, biological evaluation, and docking studies of novel triazolo[4,3-b]pyridazine derivatives as dual c-Met/Pim-1 potential inhibitors with antitumor activity
Mahmoud, Mohamed E.
Ahmed, Eman M.
Ragab, Hamdy M.
Eltelbany, Rania Farag A.
Hassan, Rasha A.
RSC ADVANCES, 2024, 14 (41) : 30346 - 30363
[27] Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors
Ma, Junlong
Chen, Heng
Yang, Jie
Yu, Zutao
Huang, Pan
Yang, Haofeng
Zheng, Bifeng
Liu, Rangru
Li, Qianbin
Hu, Gaoyun
Chen, Zhuo
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (09) : 1871 - 1881
[28] Design, synthesis and biological evaluation of novel 4,5-dihydro-[1,2,4] triazolo[4,3-f] pteridine derivatives as potential BRD4 inhibitors
Bi, Xinzhou
Li, Jieming
Li, Jiuhui
Shi, Wei
Dai, Yuxuan
Li, Qifei
Zhang, Wenjie
Huang, Wenlong
Qian, Hai
Jiang, Cheng
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (13) : 2813 - 2821
[29] Design, synthesis and biological evaluation of novel 2,3-dihydroquinazolin-4(1H)-one derivatives as potential fXa inhibitors
Xing, Junhao
Yang, Lingyun
Yang, Yifei
Zhao, Leilei
Wei, Qiangqiang
Zhang, Jian
Zhou, Jinpei
Zhang, Huibin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 411 - 422
[30] Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity
Elkotamy, Mahmoud S.
Elgohary, Mohamed K.
Alkabbani, Mahmoud Abdelrahman
Binjubair, Faizah A.
Alanazi, Manal M.
Alsulaimany, Marwa
Al-Rashood, Sara T.
Ghabbour, Hazem A.
Abdel-Aziz, Hatem A.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025,

← 1 2 3 4 5 →